Trial intelligence / Profile preview

Pure Honey vs Alvogyl for Dry Socket

NCT06456060Phase 1Recruiting

Sponsor
Watim Medical and Dental College
Start
Jun 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of Revamil in alveolar osteitis (AO) (2 arms), sponsored by Watim Medical and Dental College. Primary endpoints: Pain relief on Visual Analog Scale at 7 days and Success rate of the procedure at 2 weeks. Started Jun 2024; status: recruiting.

02

Drugs

Revamil
03

Conditions

alveolar osteitis (AO)

Beyond the preview

Go deeper on NCT06456060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06456060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call